Ladenburg lowered the firm’s price target on Strata Skin Sciences (SSKN) to $14 from $16 and keeps a Buy rating on the shares. The firm is ...
Full Year 2024 Results Key Financial Results Revenue: US$33.6m (flat on FY ...
Q4 2024 Earnings Call Transcript March 27, 2025 STRATA Skin Sciences, Inc. misses on earnings expectations. Reported EPS is $ ...
Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Strata Skin Sciences (SSKN – Research Report) yesterday. The company’s shares ...
6d
MyChesCo on MSNSTRATA Skin Sciences Reports Strong Q4 Growth and Strategic ProgressSTRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced its financial results for the fourth quarter and full-year 2024, ...
Dolev Rafaeli; President, Chief Executive Officer, Vice Chairman of the Board; STRATA Skin Sciences Inc John Gillings; Vice President of Finance; STRATA Skin Sciences Inc Ladies and gentlemen, thank ...
STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results